530 related articles for article (PubMed ID: 15895109)
1. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
Lessard A; Couture R
Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
[TBL] [Abstract][Full Text] [Related]
5. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices.
Seabrook GR; Bowery BJ; Hill RG
Eur J Pharmacol; 1995 Jan; 273(1-2):113-9. PubMed ID: 7537676
[TBL] [Abstract][Full Text] [Related]
7. Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.
De Brito Gariepy H; Couture R
Br J Pharmacol; 2010 Dec; 161(8):1868-84. PubMed ID: 20804497
[TBL] [Abstract][Full Text] [Related]
8. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
9. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
10. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
11. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum.
Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E
Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399
[TBL] [Abstract][Full Text] [Related]
12. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
14. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.
Picard P; Couture R
Br J Pharmacol; 1996 Jan; 117(2):241-9. PubMed ID: 8789375
[TBL] [Abstract][Full Text] [Related]
16. NK2 receptors mediate tachykinin-induced contractions of rat uterus during the oestrous cycle.
Moodley N; Lau WA; Pennefather JN; Story ME; Fisher L
Eur J Pharmacol; 1999 Jul; 376(1-2):53-60. PubMed ID: 10440089
[TBL] [Abstract][Full Text] [Related]
17. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
Culman J; Klee S; Ohlendorf C; Unger T
J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
19. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.
Cellier E; Barbot L; Iyengar S; Couture R
Br J Pharmacol; 1999 Jun; 127(3):717-28. PubMed ID: 10401563
[TBL] [Abstract][Full Text] [Related]
20. Cellular pathways mediating tachykinin-evoked secretomotor responses in guinea pig ileum.
MacNaughton W; Moore B; Vanner S
Am J Physiol; 1997 Nov; 273(5):G1127-34. PubMed ID: 9374711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
